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Case Report
Superimposed Fungal Ulcer after Fibrin Glue Sealant in 
Infectious Corneal Ulcer
Yong-Soo Byun, Man Soo Kim
Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, 
The Catholic University of Korea College of Medicine, Seoul, Korea
A healthy 27-year-old woman with a corneal ulcer underwent fibrin gluing with a bandage contact lens twice, due to 
an impending perforation. The ulcer lesion slowly progressed, unresponsive to topical antibiotics and amphotericin 
B. We removed the gluing patch and performed a corneal or scraping or biopsy with multiple amniotic membrane 
grafts to seal the thinned or perforated cornea. Three days after the surgery, the corneal cultures grew Fusarium, as 
well as Enterococcus faecalis. Three weeks after surgery, the outermost layer of amniotic membranes, serving as a 
temporary patch, was removed. The anterior chamber was clear without cells. The signs of infection clinically and 
symptomatically cleared up four weeks later. Two months after surgery, the lesion became enhanced by amniotic 
membranes. The use of fibrin glue in infectious keratitis should be avoided, because it not only masks the under-
lying lesion, but it also interferes with drug penetration into the underlying lesion.
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Since tissue glue was first reported in the management of 
corneal perforations in 1968 by Refojo et al. [1] and Webster 
et al. [2], it has been widely used in ophthalmology. Several 
case series have reported the successful use of tissue glues in 
various corneal and conjunctival surgeries, as well as corneal 
perforations [3-18]. Cyanoacrylate-based glue, fibrin-based 
glue, and other new synthetic agents are currently available. 
However, these glues were used cautiously in septic conditions 
because the corneal lesions might have been concealed by 
the opaqueness of the glue and resistant organisms could have 
developed. We report a case of bacterial keratitis, which was 
aggravated and superimposed by a fungal infection after the 
application of fibrin glue to manage an impending perforation. 
This is first case of a mixed infection after gluing.
Case Report
A healthy 27-year-old woman was referred to our hospital 
for a nonresponsive, progressive corneal ulcer in the left 
eye. One month before visiting our clinic, she went to a lo-
cal ophthalmic clinic complaining of irritation, redness, and 
pain in the left eye, where a corneal ulcer was diagnosed 
and topical gatifloxacin and tobramycin were given alter-
natively every hour. Her symptoms still persisted and in-
fection became aggressive, despite eyedrop application. 
The medication was increased to an hourly fortified topical 
cefazolin at a dosage of 50 mg/mL. One week after eyedrop 
application, fibrin gluing with bandage contact lens was 
done twice, due to the impending perforation of the thinned 
ulcerative area. The initial culture revealed no growth. The 
patient was then referred to our department for further 
evaluation. On examination, the best-corrected visual acui-
ty was 20 / 20 in the right eye and hand movement in the left 
eye. She had an uncertain history of keratitis in her left eye 
several years prior. A slit lamp examination of her right eye 
was unremarkable. The left eye showed a large ulcer, meas-
uring 5 × 3 mm, with an overlying fibrin gluing patch (Fig. 
1A). A lesion was located at the inferotemporal cornea, ad-
jacent to the limbal area. Severe chemosis and lid swelling 
were combined, but intraocular or orbital dissemination was 
not found on a B-scan ultrasound and an orbit computed to-
mography exam. The anterior chamber was maintained 
without chamber collapse and observed as an inflammation 
of 2+ cells without a hypopyon. Feathery-like infiltration Korean J Ophthalmol Vol.25, No.6, 2011
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Fig. 1. (A) Large ulcer, measuring 5 × 3 mm, with overlying fibrin glue, which was aggravated and unresponsive to topical broad-spectrum 
antibiotics and amphotericin B after one week. (B) Immediately after removal of the bandage contact lens and fibrin glue, a deep necrotic lesion 
under the obscure glue was observed, and micro-leaking and an iridocorneal adhesion was found at the center of thinned ulcer base.
A B
Fig. 2. (A) Three weeks after surgery, the multilayered amniotic membrane was well attached and symptomatical and clinical improvements 
were observed. (B) Two months after surgery, the outermost layer of the amniotic membranes, serving as a temporary patch, was removed and 
the lesion became totally opaque and sclerotic. The thinned area was well enhanced by permanent multiple amniotic grafts.
was observed at the margin of the lesion, even when ob-
scured by overlying fibrin glue. Topical amphotericin B 
(0.15%) was applied every hour. Corneal scraping was not 
performed and disease progression was observed for two 
days, because the lesion margin was overlaid with the glu-
ing patch and the risk of perforation was high when the glu
ing patch was handled. The ulcer lesion slowly progressed 
and the symptoms, including ocular pain, conjunctival in-
jection was aggravated. We decided to remove the gluing 
patch and perform a corneal scraping and biopsy with a 
multiple amniotic membrane graft to seal the thinned or perfo-
rated cornea. When the overlying fibrin glue was carefully 
removed, a masked lesion was revealed. Necrotic, infiltrated 
debris had expanded, surrounding the lesion, and an irido-
corneal adhesion under the ulcerative lesion was observed 
(Fig. 1B). Micro-leaking was found at the center of the thin-
ned ulcer base. Corneal scraping for microbiologic evalua-
tion was carefully done at the ulcerative base and margin 
and necrotic tissue was also debrided to improve drug 
penetration. The adhesiolysis was done between the iris and 
cornea. A three-layered amniotic membrane was patched 
over the ulcerative lesion and the outermost layer covered 
the lesion over 3 mm from the margin of the lesion, includ-
ing the half cornea and limbus. Finally, intracameral cefur-
oxime (1 mg/0.1 mL) and amphotericin B (0.5 μg/0.1 mL) 
were injected. On the second day after the surgery, the size 
of the ulcer had decreased and the conjunctival injection, lid 
swelling, ocular pain gradually improved. Three days after 
the surgery, the corneal cultures grew Fusarium, as well as 
Enterococcus faecalis. Fortunately, Enterococcus faecalis 
is susceptible to levofloxacin and cephalosporin. Topical 
amphotericin B (0.15%) and gatifloxacin were still con-
tinuously administered hourly and the patient was also start-
ed on oral itraconazole. Topical cycloplegics and anti-YS Byun, et al. Superimposed Fungal Ulcer after Fibrin Glue
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glaucomatics were added to control the pain and lowering 
the intraocular pressure, respectively. Topical amphotericin 
B and gatifloxacin were reduced to four applications per 
day after one week. Three weeks after surgery, the outer-
most layer of amniotic membranes, as the temporary patch, 
was removed. The anterior chamber was observed to be 
clear without cells (Fig. 2A). All antifungal medications 
were discontinued, as the infection sign was clinically and 
symptomatically clear four weeks later. Two months after 
surgery, the lesion was totally opaque and sclerotic and the 
thinned area was enhanced by permanent multiple amniotic 
grafts and the overlying epithelium was well maintained 
(Fig. 2B). A best-corrected visual acuity was recovered to 
20 / 60 in the left eye.
Discussion
 Corneal thinning or perforations can result from a variety 
of ocular disease states associated with trauma, acute or 
chronic inflammation. Regardless of the cause, perforation 
creates an emergent situation and prompt treatment is 
necessary. Many surgical approaches, such as tissue adhe-
sive, bandage contact lens, conjunctival flap, and ther-
apeutic penetrating keratoplasty, have been introduced to 
treat perforated ulcers of the cornea. Corneal transplant is a 
definitive treatment, but preserved cornea are of limited 
supply, and preceding temporary patching with the manage-
ment of the underlying disease is emphasized. 
 Tissue glues have been used in ophthalmology to treat 
corneal thinning and perforations, and ocular surface 
disorders. Several case series have reported the successful 
use of fibrin glues, as well as cyanoacrylate glues, in the 
management of corneal perforations. According to a report 
by Sharma et al. [19], even though the properties of cyanoa-
crylate and fibrin glue seem very different, their success in 
sealing corneal perforations appears to be similar. In the 
management of 41 corneal perforations, they found that 
both fibrin and cyanoacrylate glues were similarly very ef-
fective in the closure of corneal perforations up to 2 mm in 
diameter. 
 However, the use of tissue glue in treating infectious ul-
cerations has been limited in practice. The development of 
infectious infiltrates after prolonged cyanoacrylate glue ad-
hesion has been documented in numerous studies [14,17]. 
The symptoms and signs of the infectious ulcers may have 
been concealed by the opaqueness of the glue. Furthermore, 
the development of resistant organisms should be 
considered. For this reason, the use of antibiotic prophy-
laxis is recommended while the cyanoacrylate glue is ap-
plied and the antibiotic may be changed periodically to min-
imize the growth of resistant organisms [9]. Also, the effi-
cacy of antibiotics in treating infectious ulcerations may be 
limited due to tissue necrosis or overlying glue itself. 
 In this case, a fibrin glue without a covering layer was 
used to manage the impending perforation in infectious 
keratitis. To our knowledge, this case is the initial report in 
which a secondary infection developed after the use of fi-
brin glue, although several cases of corneal ulcers by mixed 
microorganisms were previously reported in Korea [20,21]. 
Despite the same medications, the keratitis was improved 
only by the removal of the overlying fibrin glue. We consid-
ered three aggravating factors in this case. Firstly, necrotic 
tissue and bandage contact lenses may interrupt the anti-
biotics delivery, promoting microbiologic colonization. 
Secondly, low-inflammatory properties of fibrin glue may 
prove disadvantageous in circumstances where vasculariza-
tion is desired, such as infectious ulcers. This is similar to 
the principle of conjunctival flaps in the management of re-
fractory corneal ulcers. Finally, it is assumed that the appli-
cation of fibrin glue in perforated infectious ulcers has the 
same limitations as cyanoacrylate glue. In contrast to the 
cyanoacrylate glues as synthetic adhesives, the benefits of 
fibrin glue relates to its biodegradability and flexibility. The 
bonding that occurs with fibrin glues simulate the final 
stage of the coagulation cascade, producing a biocompat-
ible fibrin matrix similar to a natural plasma clot. Although 
the fibrin glues have a lower tensile strength and slower pol-
ymerization, they may induce minimal inflammation, due 
to their being biologic and biodegradable [22]. Although 
there is no comparative study of the drug penetration be-
tween the cyanoacrylate and fibrin glues, it is expected that 
fibrin glues, which are more biocompatible than cyanoacry-
late glues, may be advantageous in their management of in-
fectious corneal perforation. In experimental studies, fibrin 
glue has also been used as a vehicle for delivering anti-
biotics and platelet gel, potentially containing natural heal-
ing factors that promote tissue regeneration [23-26]. 
However we found in this case that the application of fibrin 
glue to a perforated infectious ulcer aggravated the ulcer le-
sion and caused a secondary infection to deveop.
In conclusion, fibrin glue is useful in the treatment of cor-
neal perforations and corneal thinning, but it has also the 
risk of microbial colonization, and secondary infection, as 
with cyanoacrylate glue. The use of fibrin glue should be 
avoided, especially in infectious keratitis, and prophylactic 
antibiotics should be used even in sterile keratitis, because 
lesion can be aggravated and a secondary infections may 
develop. Future studies may reveal pharmacologic proper-
ties or biochemical effects on tissue for each of the available 
glues, and newer compounds may be developed with better 
biocompatibility or drug penetration.
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